Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR

Tanya M Laidlaw1 Jeff and Penny Vinik Center for Allergic Diseases Research, Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, MA, USA;2 Department of Medicine, Harvard Medical School, Boston, MA, USACorrespondence[email protected]

https://orcid.org/0000-0001-6709-9795 View further author information

Andrew Menzies-Gow3 Royal Brompton and Harefield Hospitals, School of Immunology and Microbial Sciences, King’s College London, London, UKView further author information

Scott Caveney4 Global Development, Inflammation, R&D, Amgen, Thousand Oaks, CA, USAView further author information

Joseph K Han5 Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USAView further author information

Nicole Martin6 Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA;7 Cytel Inc, Waltham, MA, USAView further author information

Elliot Israel8 Divisions of Pulmonary and Critical Care Medicine and Allergy and Clinical Immunology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

https://orcid.org/0000-0002-2470-856X View further author information

Jason K Lee9 Evidence Based Medical Educator Inc., Toronto, ON, Canada;10 Toronto Allergy and Asthma Clinic, Toronto, ON, CanadaView further author information

Jean-Pierre Llanos11 Global Medical Affairs, Amgen, Thousand Oaks, CA, USAView further author information

Neil Martin12 Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK;13 University of Leicester, Leicester, UKView further author information

Ayman Megally14 Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

Bhavini Parikh14 Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA

https://orcid.org/0009-0006-7374-1274 View further author information

Sylvia Vong15 Translational Science and Experimental Medicine, Early Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USAView further author information

Tobias Welte16 Department of Respiratory Medicine and German Center for Lung Research, Hannover Medical School, Hannover, Germany

https://orcid.org/0000-0002-9947-7356 View further author information

Jonathan Corren17 David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USAView further author information

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date